Ben Snider

Senior Equity Strategist, Goldman Sachs
· tracked since Feb 2026
Calls
4
Win Rate
75.0%
return
+3.3%
Calls 4 6 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 3
Best Calls
RSP Long +7.9%
XBI Long +7.0%
XLK Long +1.6%
Worst Calls
XLI Long -3.4%
Most Mentioned
SPY ×2
XLI ×1
XLK ×1
Recent Calls
XLI Long 1 month ago
XLK Long 1 month ago
XBI Long 1 month ago
Win Rate 75% Long 4 Short 0
Win Rate
7d 50%
30d 100%
90d 100%
Average Return +3.3% Long Return +3.3% Short Return -
Average Return
7d -1.4%
30d +2.9%
90d +7.0%
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
May 05
$202.83
+7.9%
Broadening market rally expected
The S&P 500 is at an all-time high but the median stock is 13% below its high, a gap not seen since the dot-com bubble. If geopolitical tensions ease and energy prices recede, the base case is a broadening of earnings and stock performance across the market, making the broader market attractive.
Equity Indexes
Long
Jul 21
$154.14
+7.0%
M&A activity lifts biopharma, tech, industrials.
With M&A announcements rising, companies likely to be acquired should trade at a valuation premium. Goldman analysts highlight three distinct groups where M&A activity and performance have been strongest: biopharma, broader tech, and a collection of stocks from other areas including industrials. All three groups have started to outperform.
Thematic ETFs
Long
Jul 21
$179.02
-3.4%
M&A activity lifts biopharma, tech, industrials.
With M&A announcements rising, companies likely to be acquired should trade at a valuation premium. Goldman analysts highlight three distinct groups where M&A activity and performance have been strongest: biopharma, broader tech, and a collection of stocks from other areas including industrials. All three groups have started to outperform.
Thematic ETFs
Long
Jul 21
$180.62
+1.6%
M&A activity lifts biopharma, tech, industrials.
With M&A announcements rising, companies likely to be acquired should trade at a valuation premium. Goldman analysts highlight three distinct groups where M&A activity and performance have been strongest: biopharma, broader tech, and a collection of stocks from other areas including industrials. All three groups have started to outperform.
Thematic ETFs
Showing 4 of 4 calls · sorted by mentions

Ben Snider has 4 trade ideas tracked on Buzzberg across 4 tickers since February 2026. Most covered: SPY, XLI, XLK.